DWK-31687-96298
2 vaccinations
3 coded responses
13 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 282 / NC
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Dose 1 — Pfizer-BioNTech
-
2021-01-15
Registered in v-safe
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: LE sorenessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Survey response — day 7, dose 1MedDRA: Eye pain, Pain of skin — Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Tender scalp. Sore eyeballsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-27
- 2021-02-04
-
2021-02-08
Dose 2 — Pfizer-BioNTech
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-10
- 2021-03-15
- 2021-03-22
-
2021-08-09
Survey response — 6 months, dose 2MedDRA: Nausea, Pain, Vomiting — Feeling: PoorFree text: Nausea emesis body achesMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-02-08 | Pfizer-BioNTech |
Call center
4 call center cases
4 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): LE soreness
Release 2 — day 7, dose 1
Systemic reaction (other): Tender scalp. Sore eyeballs
Release 9 — 6 months, dose 2
Symptoms: Nausea emesis body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nausea | ✓ | · | ✓ |
| SD | Pain | ✓ | · | ✓ |
| SD | Vomiting | ✓ | · | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Pain of skin | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release